Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update
Rigel Pharmaceuticals (Nasdaq: RIGL) has scheduled its third quarter 2024 financial results announcement for Thursday, November 7, 2024, after market close. The company will host a live conference call and webcast at 4:30 p.m. Eastern Time to discuss financial results and provide a business update. Participants can join via phone (877-407-3088 domestic, 201-389-0927 international) or through the webcast available on Rigel's website. The webcast recording will be accessible for 90 days after the call.
Rigel Pharmaceuticals (Nasdaq: RIGL) ha programmato l'annuncio dei risultati finanziari del terzo trimestre 2024 per giovedì 7 novembre 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica in diretta e un webcast alle 16:30 ora orientale per discutere dei risultati finanziari e fornire un aggiornamento sull'attività. I partecipanti possono unirsi tramite telefono (877-407-3088 nazionale, 201-389-0927 internazionale) o attraverso il webcast disponibile sul sito web di Rigel. La registrazione del webcast sarà accessibile per 90 giorni dopo la chiamata.
Rigel Pharmaceuticals (Nasdaq: RIGL) ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 para el jueves 7 de noviembre de 2024, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica en vivo y un webcast a las 4:30 p.m. hora del Este para discutir los resultados financieros y proporcionar una actualización del negocio. Los participantes pueden unirse por teléfono (877-407-3088 nacional, 201-389-0927 internacional) o a través del webcast disponible en el sitio web de Rigel. La grabación del webcast estará accesible durante 90 días después de la llamada.
리겔 제약 (Nasdaq: RIGL)는 2024년 3분기 재무 결과 발표를 2024년 11월 7일 목요일, 시장 마감 후로 예정하고 있습니다. 회사는 동부 표준시 기준 오후 4시 30분에 재무 결과를 논의하고 사업 업데이트를 제공하는 라이브 컨퍼런스 콜 및 웹캐스트를 개최합니다. 참가자는 전화(877-407-3088 국내, 201-389-0927 국제) 또는 리겔의 웹사이트에서 제공되는 웹캐스트를 통해 참여할 수 있습니다. 웹캐스트 녹음은 통화 후 90일 동안 접근 가능합니다.
Rigel Pharmaceuticals (Nasdaq: RIGL) a prévu l'annonce de ses résultats financiers pour le troisième trimestre 2024 le jeudi 7 novembre 2024, après la clôture du marché. L'entreprise organisera une conférence téléphonique en direct et un webinaire à 16h30, heure de l'Est, pour discuter des résultats financiers et fournir une mise à jour de l'activité. Les participants peuvent se joindre par téléphone (877-407-3088 national, 201-389-0927 international) ou via le webinaire disponible sur le site Web de Rigel. L'enregistrement du webinaire sera accessible pendant 90 jours après l'appel.
Rigel Pharmaceuticals (Nasdaq: RIGL) hat die Bekanntgabe seiner Finanzergebnisse für das dritte Quartal 2024 für Donnerstag, den 7. November 2024, nach Börsenschluss angesetzt. Das Unternehmen wird um 16:30 Uhr Eastern Time eine Live-Konferenzschaltung und einen Webcast veranstalten, um die Finanzergebnisse zu erörtern und ein Unternehmensupdate zu geben. Teilnehmer können per Telefon (877-407-3088 für nationale Anrufe, 201-389-0927 für internationale Anrufe) oder über den Webcast auf der Website von Rigel teilnehmen. Die Aufzeichnung des Webcasts wird 90 Tage nach dem Anruf verfügbar sein.
- None.
- None.
Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David Rosen
Argot Partners
Phone: 646.461.6387
Email: david.rosen@argotpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-third-quarter-2024-financial-results-and-business-update-302292332.html
SOURCE Rigel Pharmaceuticals, Inc.
FAQ
When will Rigel Pharmaceuticals (RIGL) report Q3 2024 earnings?
How can investors access Rigel Pharmaceuticals' (RIGL) Q3 2024 earnings call?
How long will Rigel Pharmaceuticals' (RIGL) Q3 2024 earnings webcast be available?
